Incyte
INCY
#1210
Rank
A$26.37 B
Marketcap
A$132.52
Share price
0.55%
Change (1 day)
23.05%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2024: A$0.45 Billion

According to Incyte's latest financial reports the company's current earnings are A$4.81 Billion. In 2024 the company made an earning of A$0.45 Billion a decrease over its 2023 earnings that were of A$1.19 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2024

Annual earnings

Year Earnings Change
2024A$0.45 B-62.04%
2023A$1.19 B57.66%
2022A$0.75 B-7.24%
2021A$0.81 B-345.65%
2020-A$0.34 Billion-147.7%
2019A$0.69 B322.02%
2018A$0.16 B-136.94%
2017-A$0.45 Billion-390.76%
2016A$0.15 B1322%
2015A$10.81 M-115.56%
2014-A$69.52 Million-41.4%
2013-A$0.12 Billion87.67%
2012-A$63.22 Million-74.9%
2011-A$0.26 Billion843.59%
2010-A$26.69 Million-88.68%
2009-A$0.24 Billion1.37%
2008-A$0.24 Billion86.16%
2007-A$0.13 Billion17.64%
2006-A$0.11 Billion-28.62%
2005-A$0.15 Billion-36.1%
2004-A$0.24 Billion-2.03%
2003-A$0.24 Billion22.26%
2002-A$0.2 Billion-27.39%
2001-A$0.27 Billion198.72%
2000-A$89.63 Million132.2%
1999-A$38.6 Million-556.86%
1998A$8.44 M-37.23%
1997A$13.46 M-259.32%
1996-A$8.45 Million-45.87%
1995-A$15.61 Million-9.17%
1994-A$17.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$23.41 B 929.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$16.97 B 646.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.22 B 1,316.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.80 B 419.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$95.64 M-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-A$65.77 Million-102.89%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-A$99.16 Million-104.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-A$41.59 Million-101.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$79.55 Million-103.50%๐Ÿ‡บ๐Ÿ‡ธ USA